1-3 of 3
Mitchell R. Smith
Close
Sort by
Journal Articles

Blockade of CCR1 induces a phenotypic shift in macrophages and triggers a favorable antilymphoma activity

Kang Le, Jing Sun, Javid Ghaemmaghami, Mitchell R. Smith, W. K. Eddie Ip, Tycel Phillips, Mamta Gupta
Journal: Blood Advances
Blood Adv (2023) 7 (15): 3952–3967.
https://doi.org/10.1182/bloodadvances.2022008722
Published: 2023
Includes: Supplemental data
Journal Articles

Mantle cell lymphoma polarizes tumor-associated macrophages into M2-like macrophages, which in turn promote tumorigenesis

Kang Le, Jing Sun, Hunain Khawaja, Maho Shibata, Sanjay B. Maggirwar, Mitchell R. Smith, Mamta Gupta
Journal: Blood Advances
Blood Adv (2021) 5 (14): 2863–2878.
https://doi.org/10.1182/bloodadvances.2020003871
Published: 2021
Includes: Supplemental data
Journal Articles

Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance)

Clinical Trials & Observations
John C. Byrd, Amy S. Ruppert, Nyla A. Heerema, Alese E. Halvorson, Eva Hoke, Mitchell R. Smith, John E. Godwin, Stephen Couban, Todd A. Fehniger, Michael J. Thirman, Martin S. Tallman, Frederick R. Appelbaum, Richard M. Stone, Sue Robinson, Julie E. Chang, Sumithra J. Mandrekar, Richard A. Larson
Journal: Blood Advances
Blood Adv (2018) 2 (14): 1705–1718.
https://doi.org/10.1182/bloodadvances.2017015396
Published: 2018
Includes: Supplemental data